A proposed US ban on menthol cigarettes and flavoured cigars, which would also apply to heated tobacco products – currently regulated as conventional cigarettes – has stirred up strong passions either way
Cristine Delnevo, the new chair of the US FDA’s Tobacco Products Scientific Advisory Committee (TPSAC), has been hailed as an “objective, thoughtful scientist” with an understanding of research into harm reduction
The US Food and Drug Administration (FDA)’s warning over flavoured nicotine gummies has been welcomed by public health organisations, while it has not gone down well with representatives of the vaping industry
Japan currently has no intention of following the US and Europe with a ban on menthol-flavoured tobacco products
The Democratic governor of Hawaii appeared to take a step out of line with the US party’s common position when he vetoed a bill that would have introduced a ban on flavoured tobacco products
The US Food and Drug Administration (FDA) has issued a warning letter to a Florida-based manufacturer for marketing flavoured nicotine gummies – the first such warning over this type of product
While nicotine pouches are growing in popularity fast, the state of science on their safety remains threadbare
22nd Century Group has announced that its very low nicotine (VLN) cigarettes pilot in Chicago is exceeding expectations, leading the company to accelerate its launch plans
Altria saw $12.43bn in revenue in the first half of 2022 – a decrease of 4.1% from the same period a year ago – but was encouraged by the positive momentum of its nicotine pouch brand On!
British American Tobacco (BAT) saw revenue from its new products category portfolio rise by 45% in the first half of the year, with good returns from its modern oral and heated tobacco portfolio
The tobacco industry has little faith that the upcoming external review of the Center for Tobacco Products (CTP) will help fix faults in the US FDA department’s regulation of new tobacco and alternative products
Swedish Match has reported a 17% sales increase in the first half of the year, driven by smoke-free products, with solid growth for its Zyn nicotine pouches in both the US and Scandinavian markets
Philip Morris International (PMI) has raised its full year outlook after it saw decent numbers over the first half of 2022
US Food and Drug Administration (FDA) commissioner Robert Califf has authorised an external review of the Center for Tobacco Products (CTP), citing a “series of challenges that have…stressed the agency’s operations”
Flavours in nicotine pouches could become the next contentious issue for tobacco alternatives, following a similar route to e-liquid flavours, experts say
Details remain sketchy as to how and when the US Food and Drug Administration (FDA)’s plan to impose nicotine restrictions on cigarettes is to be implemented
22nd Century Group has confirmed the first international shipments of very low nicotine (VLN) cigarettes to South Korea and is expecting to see significant benefits from the sales of its menthol line of VLN cigarettes as it plans an expansion of sales and distribution in the US beyond its initial trial in Chicago, Illinois
On international World No Tobacco Day tobacco alternatives such as pouches were not excluded from the criticisms
Swedish Match saw its smoke-free portfolio continuing to drive sales as well as increase operating profits in the first quarter of 2022, compared with the same period in 2021, and attributed this positive performance to “strong momentum for the US smoke-free business”
The board of Swedish Match has asked shareholders of the Scandinavian nicotine pouch maker to accept a $16bn takeover offer from tobacco giant Philip Morris International (PMI)
Philip Morris International (PMI) is in talks to buy European rival Swedish Match in an estimated $15bn deal that could affect both the oral and smoking tobacco markets
The FDA is looking to ban menthol-flavoured cigarettes and all characterising flavours other than tobacco in cigars – a move that would also likely eliminate the possibility of flavours in products such as heated tobacco
Altria saw $5.9bn in revenue in Q1 2022 – a decrease from both Q4 2021 ($6.25bn) and by 2.4% compared to Q1 2021
Philip Morris International (PMI) saw positive numbers for the first quarter of 2022, with Iqos Iluma performing well in Japan, Switzerland and Spain
A reply from Los Angeles County lawyers is expected soon, after RJ Reynolds Tobacco Company and two other tobacco companies asked a federal appellate court to review its earlier affirmation of the county’s ban on flavoured tobacco sales
A new study suggests awareness of nicotine pouches among young US adult smokers is high, given the low market penetration of oral tobacco products in the country
While synthetic nicotine has become the focus of much controversy, demonised as a public health risk, its currently poor reputation derives more from bureaucracy than from the substance itself
TobaccoIntelligence has put together a timeline outlining the major points to look out for over the summer as the US FDA brings synthetic nicotine into the premarket tobacco product application (PMTA) process
The US Food and Drug Administration (FDA) has authorised the marketing of Logic Technology Development’s heated tobacco product Vapeleaf
Michele Mital, deputy director of the US Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP) since 2018, looks the most likely candidate to take over from retiring director Mitch Zeller